Expert Insights on NSCLC: Unmet Needs and Innovations from ASCO 2024

Jason Porter, MD, outlines the most significant unaddressed challenges in treating and managing non-small cell lung cancer as the field approaches the American Society of Clinical Oncology's 2024 annual meeting.

Now Viewing

EP: 1.Expert Insights on NSCLC: Unmet Needs and Innovations from ASCO 2024

EP: 2.ASCO 2024: Key Findings of the LAURA Trial on Osimertinib for EGFR-Mutated NSCLC

EP: 3.Evaluating Amivantamab and Lazertinib: Key Findings from the CHRYSALIS-2 Study at ASCO 2024

EP: 4.Insights from the TROPION-Lung05 Trial at ASCO 2024

EP: 5.Long-Term Follow-Up from CheckMate 9LA at ASCO 2024

EP: 6.ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions

Related Videos

Related Content

Advertisement

December 21st 2024

ICYMI: Highlights From ASCO 2024

Pearl Steinzor

Top coverage from the 2024 American Society of Clinical Oncology (ASCO) annual meeting included research topics in non-small cell lung cancer (NSCLC), multiple myeloma, metastatic colorectal cancer (mCRC), and more.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

December 20th 2024

ICYMI: AHA 2024 Scientific Session Highlights

Brooke McCormick

Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights and highlighted promising treatments.

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

December 19th 2024

Infection Rate More Than Double in CLL/SLL Accompanied By Secondary Immunodeficiency Disease

Karen Jacobson-Sive

Secondary immunodeficiency disease (SID) status was associated with significantly higher risk for severe bacterial infections in adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

December 19th 2024

Further Refining the Myasthenia Gravis Continuum

Gayle Turim Dickstein

Finding similar frequencies of positive acetylcholine receptor antibodies in patients with ocular and generalized myasthenia gravis (MG), a Danish research team posits that ocular disease is most likely a more moderate form of generalized MG—not a fully separate condition.

Related Content

Advertisement

December 21st 2024

ICYMI: Highlights From ASCO 2024

Pearl Steinzor

Top coverage from the 2024 American Society of Clinical Oncology (ASCO) annual meeting included research topics in non-small cell lung cancer (NSCLC), multiple myeloma, metastatic colorectal cancer (mCRC), and more.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

December 20th 2024

ICYMI: AHA 2024 Scientific Session Highlights

Brooke McCormick

Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights and highlighted promising treatments.

October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi

Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.

December 19th 2024

Infection Rate More Than Double in CLL/SLL Accompanied By Secondary Immunodeficiency Disease

Karen Jacobson-Sive

Secondary immunodeficiency disease (SID) status was associated with significantly higher risk for severe bacterial infections in adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

December 19th 2024

Further Refining the Myasthenia Gravis Continuum

Gayle Turim Dickstein

Finding similar frequencies of positive acetylcholine receptor antibodies in patients with ocular and generalized myasthenia gravis (MG), a Danish research team posits that ocular disease is most likely a more moderate form of generalized MG—not a fully separate condition.